occurs in patients with poorly controlled haemostasis. Intracranial haemorrhage may also occur in anticoagulated patients with carefully controlled haemostasis as manifested by coagulation results (bleeding time, prothrombin time, partial thromboplastin time) which are within the accepted therapeutic range. I wish to describe the fluid-blood level in five anticoagulated patients with intracranial haemorrhages.
A typical case history is that of a 57 year old normotensive woman with a history of two prior myocardial infarctions and was admitted to hospital because of substernal chest pain. In patients with normal haemostasis who develop an intracranial haemorrhage, CT shows-a homogeneously nonenhancing hyperdense lesion in the acute stage. In certain anticoagulated patients, the appearance of the acute haematoma may be different, with the finding of a fluid-blood interface which is unique for this condition.2 It is believed that the fluid seen above the haematoma represents plasma; the layering is a sedimentation effect. This appearance of layering within the haematoma was seen in all our patients. This fluid-blood interface occurred when there was not adequate hemostasis. When anticoagulant medication was discontinued and coagulation studies returned to normal, CT showed hyperdense hematoma without the fluid-blood interface.
This change was seen in two of these patients. The finding of intracranial fluid-blood interface has been seen in patients with peritumoural haemorrhage3 and ruptured arteriovenous malformations. 4 In patients with angiomas, the origin of the fluid-blood level is believed to be haemorrhage into cystic spaces. The fluid-blood level has been reported with primary (glioblastoma multiforme) and metastatic neoplasms (melanoma, lung). In neoplastic conditions in which a fluid-blood interface is seen, there is frequently enhancement at the lesion periphery. In one report, fluid-blood level was seen in patients with spontaneous intracerebral haematoma without any identified aetiology or abnormal haemostasis.5 In these cases several potential mechanisms for fluid-blood level were postulated; (1) haemorrhage was acute and clotting of extravasated blood had not been completed when CT performed, (2) large haematoma occurs within the brain using up all clotting factors to result in two components and create fluid-blood interface. If either of these mechanisms were responsible for the fluid-blood interface, we would have expected this finding of fluidblood interface to be common in other intracerebral haematomas. We have not seen this finding in nontumorous intracerebral haemorrhage unless there was impaired haemostasis, as seen in these five patients. LEON 
